Assets
(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | Interferon beta receptor (type I IFN signaling) · Type I interferon receptorBiologic (subtype unspecified) | Multiple Sclerosis | |
Somatropin(Serostim) | Approved | Growth hormone receptorProtein / enzyme therapeutic | HIV |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.